Patent details

EP2575784 Title: ORAL DOSAGE FORMS OF BENDAMUSTINE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2575784
WO Application Number:
EP2011002764
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP11727396.1
WO Publication Number:
WO2011151087
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Germany (DE)
Publications:

Dates

Filing date:
01/06/2011
Grant date:
08/08/2018
EP Publication Date:
10/04/2013
WO Publication Date:
08/12/2011
Claims Translations Received Date:
Claims Translation B1 Received Date:
02/10/2018
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
08/08/2018
EP B1 Publication Date:
08/08/2018
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
31/05/2031
Lapsed By Expiration Date:
Patent Validated Date:
16/10/2018
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
02/02/2023
 
 

 

Name:
PHARMA& SCHWEIZ GMBH
Address:
Riedstrasse 1, 6330, Cham, Switzerland (CH)

Historical Applicant/holder

From:
02/02/2023
To:
02/02/2023

 

Name:
Astellas Deutschland GmbH
Address:
Ridlerstraße 57, 80339, München, Germany (DE)

From:
08/08/2018
To:
02/02/2023

 

Name:
Astellas Deutschland GmbH
Address:
Georg-Brauchle-Ring 64-66, 80992 MÜNCHEN, Germany (DE)

Agent

Name:
drs. O. Griebling
From:
15/10/2018
Address:
p/a Octrooibureau Griebling B.V. Sportweg 10, 5037 AC, Tilburg, Netherlands (NL)
To:

Inventor

1

Name:
COLLEDGE, Jeffrey
Address:
2300 AH Leiden, Netherlands (NL)

2

Name:
OLTHOFF, Margaretha
Address:
2300 AH Leiden, Netherlands (NL)

Priority

1

Priority Patent Number:
10075231
Priority Date:
02/06/2010
Priority Country:
European Patent Office (EPO) (EP)

2

Priority Patent Number:
11075047
Priority Date:
14/03/2011
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC or IDT classification:
A61K 9/14; A61K 9/48; A61K 31/4184; A61K 47/10;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
07/23
Publication date:
15/02/2023
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
EP3
Journal edition number:
43/18
Publication date:
17/10/2018
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
33/18
Publication date:
08/08/2018
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201832
Publication date:
08/08/2018
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202300280B
Date Registered:
02/02/2023
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
drs. O. Griebling
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
PHARMA& SCHWEIZ GMBH
Address:
Riedstrasse 1, 6330, Cham, Switzerland (CH)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
RC202300280A
Date Registered:
02/02/2023
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
drs. O. Griebling
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
30/06/2025
Annual Fee Number:
15
Annual Fee Amount:
900 Euro
Last Annual Payment Date:
19/06/2024
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
800 Euro
Payer:
Dennemeyer and Co
Filing date Document type Document Description Number of pages File Type
15/10/2018 Outgoing Correspondence Letter no formal defects 1 PDF /5/0/3/9/9/0800299305/docs/ep11727396.1_1_233476l271.pdf
02/10/2018 Claims First filed claims 2 PDF /5/0/3/9/9/0800299305/docs/ep11727396.1_0_claims20181003100144342.pdf
02/10/2018 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /5/0/3/9/9/0800299305/docs/ep11727396.1_2_incomingcorrespondencepaper20181003100144274.pdf
02/10/2018 Incoming Correspondence Paper Other 1 PDF /5/0/3/9/9/0800299305/docs/ep11727396.1_3_incomingcorrespondencepaper20181003100144395.pdf